In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.
Check out the Communication page for the complete details by clicking the link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
The new online Learning Center with new content can still be found under the “Training” folder on ...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...